Victory Capital Management
SLNO

Victory Capital Management’s Soleno Therapeutics SLNO Stock Holding History

Victory Capital Management’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,732
Closed -$543K – 2488
2025
Q4 		$543K Sell
11,732
-29,795
-72% -$1.63M ﹤0.01% 1995
2025
Q3 		$2.81M Buy
41,527
+32,374
+354% +$2.4M ﹤0.01% 1514
2025
Q2 		$767K Buy
9,153
+5,116
+127% +$383K ﹤0.01% 1946
2025
Q1 		$288K Buy
+4,037
New +$197K ﹤0.01% 2142
2024
Q4 		– Sell
-13,509
Closed -$682K – 2531
2024
Q3 		$682K Buy
13,509
+2,782
+26% +$133K ﹤0.01% 1926
2024
Q2 		$438K Buy
10,727
+2,236
+26% +$94.8K ﹤0.01% 2012
2024
Q1 		$363K Buy
+8,491
New +$384K ﹤0.01% 2069
2022
Q2 		– Sell
-892
Closed -$3K – 2743
2022
Q1 		$3K Buy
+892
New +$4.62K ﹤0.01% 2717
2020
Q2 		– Sell
-381
Closed -$14K – 3176
2020
Q1 		$14K Buy
+381
New +$16.2K ﹤0.01% 2971
2019
Q4 		– Sell
-172
Closed -$4K – 3189
2019
Q3 		$4K Buy
+172
New +$5.49K ﹤0.01% 3518

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Victory Capital Management's SLNO Position: Q1 2026 in Review

Victory Capital Management sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 11,732 shares — an estimated $543K sold.

Victory Capital Management first reported a position in SLNO in Q3 2019 and held it in 10 quarters. The position peaked at $2.81M in Q3 2025. 227 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Victory Capital Management reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Victory Capital Management sold 11,732 Soleno Therapeutics shares in Q1 2026, an estimated $543K.
  • Victory Capital Management first reported a position in Soleno Therapeutics in Q3 2019 and held it in 10 quarters.
  • Victory Capital Management's Soleno Therapeutics position peaked at $2.81M in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.